These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 23847222)

  • 1. Cutting edge: flow cytometry in myelodysplastic syndromes.
    van de Loosdrecht AA; Westers TM
    J Natl Compr Canc Netw; 2013 Jul; 11(7):892-902. PubMed ID: 23847222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Standardization of flow cytometry in myelodysplastic syndromes: a report from an international consortium and the European LeukemiaNet Working Group.
    Westers TM; Ireland R; Kern W; Alhan C; Balleisen JS; Bettelheim P; Burbury K; Cullen M; Cutler JA; Della Porta MG; Dräger AM; Feuillard J; Font P; Germing U; Haase D; Johansson U; Kordasti S; Loken MR; Malcovati L; te Marvelde JG; Matarraz S; Milne T; Moshaver B; Mufti GJ; Ogata K; Orfao A; Porwit A; Psarra K; Richards SJ; Subirá D; Tindell V; Vallespi T; Valent P; van der Velden VH; de Witte TM; Wells DA; Zettl F; Béné MC; van de Loosdrecht AA
    Leukemia; 2012 Jul; 26(7):1730-41. PubMed ID: 22307178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rationale for the clinical application of flow cytometry in patients with myelodysplastic syndromes: position paper of an International Consortium and the European LeukemiaNet Working Group.
    van de Loosdrecht AA; Ireland R; Kern W; Della Porta MG; Alhan C; Balleisen JS; Bettelheim P; Bowen DT; Burbury K; Eidenschink L; Cazzola M; Chu SS; Cullen M; Cutler JA; Dräger AM; Feuillard J; Fenaux P; Font P; Germing U; Haase D; Hellström-Lindberg E; Johansson U; Kordasti S; Loken MR; Malcovati L; te Marvelde JG; Matarraz S; Milne T; Moshaver B; Mufti GJ; Nikolova V; Ogata K; Oelschlaegel U; Orfao A; Ossenkoppele GJ; Porwit A; Platzbecker U; Preijers F; Psarra K; Richards SJ; Subirá D; Seymour JF; Tindell V; Vallespi T; Valent P; van der Velden VH; Wells DA; de Witte TM; Zettl F; Béné MC; Westers TM
    Leuk Lymphoma; 2013 Mar; 54(3):472-5. PubMed ID: 22916713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiparameter flow cytometry is instrumental to distinguish myelodysplastic syndromes from non-neoplastic cytopenias.
    Cremers EMP; Westers TM; Alhan C; Cali C; Wondergem MJ; Poddighe PJ; Ossenkoppele GJ; van de Loosdrecht AA
    Eur J Cancer; 2016 Feb; 54():49-56. PubMed ID: 26720403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiparameter flow cytometry provides independent prognostic information in patients with suspected myelodysplastic syndromes: A study on 804 patients.
    Kern W; Bacher U; Haferlach C; Alpermann T; Schnittger S; Haferlach T
    Cytometry B Clin Cytom; 2015; 88(3):154-64. PubMed ID: 25581461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a Bone Marrow Dysmyelopoiesis Immunophenotypic Index for the Diagnosis and Prognosis of Myelodysplastic Syndromes.
    Verigou E; Lampropoulou P; Smyrni N; Kolliopoulou G; Sakellaropoulos G; Starakis I; Zikos P; Solomou E; Symeonidis A; Karakantza M
    Cardiovasc Hematol Disord Drug Targets; 2015; 15(2):148-61. PubMed ID: 26126819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of cytomorphology, cytogenetics, molecular genetics, and immunophenotyping in a comprehensive diagnostic workup of myelodysplastic syndromes.
    Bacher U; Haferlach T; Kern W; Weiss T; Schnittger S; Haferlach C
    Cancer; 2009 Oct; 115(19):4524-32. PubMed ID: 19569249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implementation of erythroid lineage analysis by flow cytometry in diagnostic models for myelodysplastic syndromes.
    Cremers EM; Westers TM; Alhan C; Cali C; Visser-Wisselaar HA; Chitu DA; van der Velden VH; Te Marvelde JG; Klein SK; Muus P; Vellenga E; de Greef GE; Legdeur MC; Wijermans PW; Stevens-Kroef MJ; Silva-Coelho PD; Jansen JH; Ossenkoppele GJ; van de Loosdrecht AA;
    Haematologica; 2017 Feb; 102(2):320-326. PubMed ID: 27658438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Research advances in value of flow cytometric immunophenotyping in diagnosis and prognostic evaluation of myelodysplastic syndrome].
    Lu D; Liu YR
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Jun; 21(3):785-90. PubMed ID: 23815941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of flow cytometry in myelodysplastic syndromes: diagnosis, classification, prognosis and response assessment.
    Burbury KL; Westerman DA
    Leuk Lymphoma; 2014 Apr; 55(4):749-60. PubMed ID: 23808833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flow cytometry diagnosis in myelodysplastic syndrome: Current practice in Latin America and comparison with other regions of the world.
    Grille S; Iastrebner M; Lorand-Metze I; van der Velden VHJ; Ikoma MRV; Vidal-Senmache G; Colado E; Rabelo-Carrasco LJ; Blanco A; Huamán-Garaicoa F; O'Connor JE; Cao Pochintesta C; Jensen E; Bacal NS; Díaz L; Lens D
    Leuk Res; 2019 Apr; 79():69-74. PubMed ID: 30773246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of flow cytometry for myelodysplastic syndromes: Pitfalls and technical considerations.
    Alhan C; Westers TM; Cremers EM; Cali C; Ossenkoppele GJ; van de Loosdrecht AA
    Cytometry B Clin Cytom; 2016 Jul; 90(4):358-67. PubMed ID: 26517178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical application of flow cytometry in patients with unexplained cytopenia and suspected myelodysplastic syndrome: A report of the European LeukemiaNet International MDS-Flow Cytometry Working Group.
    van de Loosdrecht AA; Kern W; Porwit A; Valent P; Kordasti S; Cremers E; Alhan C; Duetz C; Dunlop A; Hobo W; Preijers F; Wagner-Ballon O; Chapuis N; Fontenay M; Bettelheim P; Eidenschink-Brodersen L; Font P; Johansson U; Loken MR; Te Marvelde JG; Matarraz S; Ogata K; Oelschlaegel U; Orfao A; Psarra K; Subirá D; Wells DA; Béné MC; Della Porta MG; Burbury K; Bellos F; van der Velden VHJ; Westers TM; Saft L; Ireland R
    Cytometry B Clin Cytom; 2023 Jan; 104(1):77-86. PubMed ID: 34897979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementation of flow cytometry in the diagnostic work-up of myelodysplastic syndromes in a multicenter approach: report from the Dutch Working Party on Flow Cytometry in MDS.
    Westers TM; van der Velden VH; Alhan C; Bekkema R; Bijkerk A; Brooimans RA; Cali C; Dräger AM; de Haas V; Homburg C; de Jong A; Kuiper-Kramer PE; Leenders M; Lommerse I; te Marvelde JG; van der Molen-Sinke JK; Moshaver B; Mulder AB; Preijers FW; Schindhelm RK; van der Sluijs A; van Wering ER; Westra AH; van de Loosdrecht AA;
    Leuk Res; 2012 Apr; 36(4):422-30. PubMed ID: 21982641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Standardization of flow cytometry in myelodysplastic syndromes: report from the first European LeukemiaNet working conference on flow cytometry in myelodysplastic syndromes.
    van de Loosdrecht AA; Alhan C; Béné MC; Della Porta MG; Dräger AM; Feuillard J; Font P; Germing U; Haase D; Homburg CH; Ireland R; Jansen JH; Kern W; Malcovati L; Te Marvelde JG; Mufti GJ; Ogata K; Orfao A; Ossenkoppele GJ; Porwit A; Preijers FW; Richards SJ; Schuurhuis GJ; Subirá D; Valent P; van der Velden VH; Vyas P; Westra AH; de Witte TM; Wells DA; Loken MR; Westers TM
    Haematologica; 2009 Aug; 94(8):1124-34. PubMed ID: 19546437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Role of flow cytometric immunophenotyping in diagnosis of myelodysplastic syndromes--review].
    Zhang Y; Li X
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Dec; 16(6):1477-81. PubMed ID: 19099668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiparameter flow cytometry in the evaluation of myelodysplasia: Analytical issues: Recommendations from the European LeukemiaNet/International Myelodysplastic Syndrome Flow Cytometry Working Group.
    Porwit A; Béné MC; Duetz C; Matarraz S; Oelschlaegel U; Westers TM; Wagner-Ballon O; Kordasti S; Valent P; Preijers F; Alhan C; Bellos F; Bettelheim P; Burbury K; Chapuis N; Cremers E; Della Porta MG; Dunlop A; Eidenschink-Brodersen L; Font P; Fontenay M; Hobo W; Ireland R; Johansson U; Loken MR; Ogata K; Orfao A; Psarra K; Saft L; Subira D; Te Marvelde J; Wells DA; van der Velden VHJ; Kern W; van de Loosdrecht AA
    Cytometry B Clin Cytom; 2023 Jan; 104(1):27-50. PubMed ID: 36537621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunophenotyping for diagnosis and prognosis in MDS: ready for general application?
    Cremers EM; Alhan C; Westers TM; Ossenkoppele GJ; van de Loosdrecht AA
    Best Pract Res Clin Haematol; 2015 Mar; 28(1):14-21. PubMed ID: 25659726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A series of case studies illustrating the role of flow cytometry in the diagnostic work-up of myelodysplastic syndromes.
    Westers TM; Saft L; van der Velden VHJ; Te Marvelde JG; Dunlop A; Ireland R; Valent P; Porwit A; Béné MC; van de Loosdrecht AA
    Cytometry B Clin Cytom; 2023 Jan; 104(1):87-97. PubMed ID: 35179296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic Value of Flow Cytometry Standardized Using the European LeukemiaNet for Myelodysplastic Syndrome.
    Takeuchi A; Imataki O; Kubo H; Kondo A; Seo K; Uemura M; Yamaoka G; Murao K; Takeuchi A
    Acta Haematol; 2020; 143(2):140-145. PubMed ID: 31330512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.